Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SVA.TOthis companySernova Corp.	CA$0.12	-3.13×	-1.96×	0×	-3.65×	-162.9%	0.0%	0.0%	0.0%	62.8%	74.1%	-22.2%	-0.19×	-0.31×	-20.04×	0.02×	0.0%	3	-767.78	2	C
BCT.TOBriaCell Therapeutics Corp.	CA$5.51	-0.68×	1.47×	0×	-0.39×	-83.3%	0.0%	0.0%	0.0%	-216.0%	-234.6%	-120.9%	0×	0.27×	0×	2.76×	0.0%	1	-10.15	2	C
COV.VCovalon Technologies Ltd.	CA$4.31	27.96×	1.87×	1.75×	14.09×	-262.9%	53.2%	5.4%	6.3%	6.7%	5.3%	2.9%	0.07×	-5.02×	0×	8.36×	0.0%	7	15.85	4	A-
DTC.CNDefence Therapeutics Inc.	CA$0.36	-4×	7.79×	0×	-5.53×	-98.2%	0.0%	0.0%	0.0%	-190.7%	-94.2%	-17.4%	0.49×	0.03×	-12.15×	3.42×	0.0%	2	-5.63	1	C-
HEM.VHemostemix Inc.	CA$0.05	-3.13×	-2.96×	0×	-4.14×	-154.2%	0.0%	0.0%	0.0%	94.8%	637.9%	-30.8%	-0.72×	-0.69×	-10.05×	0.49×	0.0%	1	-454.38	2	C
LEEF.CNLeef Brands Inc.	CA$0.25	-2.1×	-4.7×	1.12×	-4.72×	-1263.6%	30.1%	-15.1%	-50.7%	213.2%	-18.0%	-3.8%	-1.52×	-1×	-2.22×	0.98×	0.0%	4	-3.35	2	C+
Peer median	—	-2.1×	1.47×	0×	-4.14×	-154.2%	0.0%	0.0%	0.0%	6.7%	-18.0%	-17.4%	0×	-0.69×	-2.22×	2.76×	0.0%	2	-5.63	2	—